EGFR and lung carcinoma: While early liquid biopsy approaches focused on single genes such as epidermal growth factor receptor (EGFR) [23], these have rapidly been eclipsed by multigene assays, given the growing number of actionable biomarkers both at lung cancer diagnosis and for treatment resistance.